Cutaneous necrosis associated with recombinant interferon injection.
Weinberg
J M
JM
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000008:administration & dosage / Q000009:adverse effects*; D009336:Necrosis; D011994:Recombinant Proteins; D012867:Skin / Q000098:blood supply / Q000473:pathology*; D017445:Skin Diseases, Vascular / Q000209:etiology; D012883:Skin Ulcer / Q000209:etiology; D020246:Venous Thrombosis / Q000209:etiology
D000276:Adjuvants, Immunologic; D011994:Recombinant Proteins; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a